Danish medical device company Brainreader has launched its new Neuroreader software, which is designed to detect changes in a patient's brain volume.
Neuroreader analyzes MRI scans of patients' brains and benchmarks it against a cleared U.S. Food and Drug Administration (FDA) database of healthy brain tissues. The software measures 45 structures within the brain.
In patients with signs of neurodegenerative diseases, images may be uploaded to the Brainreader server. Neuroreader then analyses the MRI scan and delivers an automated report in less than five minutes, indicating which brain structures' volume are abnormal and to what extent, according to the vendor.
The FDA-cleared Neuroreader is sold as software-as-a-service and is available to hospitals' radiology and neuroradiology departments on a pay-per-use or subscription model.
